No description available.

Airway epithelial damage is commonly found in asthma patients. Epithelial damage was investigated with special reference to contacts between epithelial cells. Eosinophils, common in allergic asthma, secrete cationic proteins, particularly major basic protein (MBP). The effect of poly-L-arginine, an analogue of MBP, on airway epithelial cells was investigated. Poly-L-arginine induced membrane damage, resulting in increased permeability, loss of cell-cell contracts (tight junctions and desmosomes) and generalized cell damage. Adhesion molecules on airway epithelial cells may be important in recruiting leukocytes. Interferon (IFN)-γ increased intracellular adhesion molecule-1 expression in airway epithelial cell lines. A combination of interleukin-4 and IFN-γ opened the tight junctions. Epithelial damage in asthma was studied at the ultrastructural level in bronchial biopsies from patients with atopic or non-atopic asthma, and healthy controls. Epithelial damage was extensive in both asthma groups. In basal and columnar cells, relative desmosome length was reduced by 30-40%. In columnar cells, half-desmosomes were noticed. Changes tended to be more extensive in atopic asthma, but there was no significant difference between the two groups. Reduced desmosomal contact may be important in the epithelial shedding observed in asthma. The contact area between columnar cells and basal lamina is relatively small in the human airway. Attachment of columnar cells to the basal lamina occurs indirectly, via desmosomal attachment to basal cells. Direct attachment of columnar cells to the basal lamina is weakened in asthmatics. Nasal polyposis is a chronic inflammatory disease often associated with asthma. An ultrastructural study showed that epithelial damage of columnar cells is more pronounced in allergic patients. The length of columnar cell desmosomes was significantly reduced in asthmatics vs. non-asthmatics, and in allergics vs. non-allergics. Cell contacts in airway epithelium in asthmatics are weakened, which may be an intrinsic feature or due to the presence of eosinophils producing toxic proteins.

No description available.

La fibrose kystique (FK), causée par des mutations dans le gène codant pour le canal chlorure CFTR, est caractérisée par des infections bactériennes chroniques des voies aériennes (VA), impliquant en particulier Pseudomonas aeruginosa (PA) et Staphylococcus aureus (SA). Les facteurs de virulence (VirF) sécrétés par celles-ci sont responsables de la destruction progressive des VA et altèrent la capacité de réparation du tissu épithélial. Il existe cependant des molécules spécifiques permettant de corriger le défaut de CFTR et de moduler l’activité de canaux potassiques, deux actions qui pourraient favoriser la réparation épithéliale de par leur action. Leur efficacité pourrait toutefois être altérée par les VirF de P. aeruginosa ou S. aureus. Mon objectif a été d’identifier le potentiel de réparation épithélial du Trikafta et du ML277, modulateurs respectivement spécifiques des canaux CFTR et KvLQT1 (canal potassique sensible au voltage, du syndrome du QT long), impliqués dans les processus de réparation. Des cultures primaires de cellules bronchiques des VA de patients FK ont été traitées avec la triple combinaison de modulateurs de CFTR Trikafta, l’activateur de KvLQT1 ML277, et la combinaison de ces deux derniers, en plus d’être exposées aux VirF de cultures de P. aeruginosa ou S. aureus. L’efficacité de ces traitements sur les processus de réparation fut évaluée, suite à des lésions, selon la vitesse de réparation des plaies, la prolifération cellulaire et les dynamiques de migration guidée cellulaire. Les VirF de P. aeruginosa et S. aureus altèrent la vitesse de fermeture lésionnelle, la prolifération cellulaire et les dynamiques de migration cellulaire. Les traitements Trikafta et ML277 permettent cependant d’améliorer ces processus de la réparation épithéliale, et ce, en absence comme en présence des VirF bactériens nocifs à la réparation. La combinaison du Trikafta et du ML277 n’amène cependant pas l’effet additif espéré sur la réparation épithéliale. Ces résultats témoignent finalement de l’effet bénéfique du Trikafta et du ML277 sur la réparation épithéliale malgré la condition infectieuse, favorisant l’intégrité fonctionnelle de l’épithélium des VA FK. / Cystic fibrosis (CF), caused by mutations in the gene coding for the chloride channel CFTR, is characterized by chronic bacterial infections in the airways, particularly by Pseudomonas aeruginosa (PA) and Staphylococcus aureus (SA). The virulence factors (VirF) secreted by these bacteria are responsible for the progressive destruction of the airways and impair the repair process of the epithelia. Nevertheless, there are specific molecules that correct the CFTR defect and modulate potassium channel activity, both of which could be beneficial at promoting epithelial repair. However, their efficacy could be altered by P. aeruginosa or S. aureus VirF. My objective was to identify the repair potential of Trikafta and ML277, respectively specific modulators of CFTR and KvLQT1 channels, involved in repair processes. Primary cultures of airways epithelial cells from CF patients were treated with the triple combination of CFTR modulators Trikafta, the KvLQT1 activator ML277, and the combination of the latter two, in addition to being exposed to VirF from P. aeruginosa or S. aureus cultures. The efficacy of these treatments on repair processes was evaluated, following wound injury, by the rate of wound repair, cell proliferation and guided cell migration dynamics. P. aeruginosa and S. aureus VirF alter wound repair rates, cell proliferation and cell migration dynamics. Nevertheless, Trikafta and ML277 treatments improve these epithelial repair processes, both in the absence and presence of repair-damaging P. aeruginosa or S. aureus VirF. However, the combination of Trikafta and ML277 did not have the hoped-for additive effect on epithelial repair. Overall, these results show the beneficial effect of Trikafta and ML277 epithelial repair despite the infectious condition, promoting the functional integrity of the CF airways epithelia.